top of page
< Back

Zidovudine


Mechanism of action:

Zidovudine is a nucleoside reverse transcriptase inhibitor and a thymidine analog. After entering host cells, it undergoes sequential phosphorylation by intracellular kinases to form the active metabolite zidovudine-5'-triphosphate. Zidovudine-5'-triphosphate competes with dTTP and is incorporated into newly synthesized viral DNA by HIV reverse transcriptase. Because zidovudine lacks a 3'-OH group, its incorporation causes termination of viral DNA synthesis.

Reference(s):

1. De Clercq E et al. (1994). HIV resistance to reverse transcriptase inhibitors. Biochem Pharmacol. 


2. Yarchoan R et al. (1988). AIDS therapies. Sci Am. 


3. Connor EM et al. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med.

bottom of page